Machine Learning (ML) in The Pharmaceutical Industry Market Forecast Signals New Revenue Opportunities Through 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Machine Learning (ML) in The Pharmaceutical Industry Market CAGR Analysis And Future Market Development
The market size of machine learning (ML) in the pharmaceutical sector has expanded at an exponential rate in recent years. It is projected to increase from $4.08 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 35.4%. This historical growth has been driven by factors such as higher research and development spending in pharmaceuticals, the integration of AI and ML into drug discovery processes, a growing incidence of chronic illnesses, progress in computational biology, and partnerships between pharmaceutical firms and technology companies.
Over the coming years, the market for machine learning within the pharmaceutical industry is forecast to undergo rapid expansion. By 2030, it is projected to reach $18.71 billion, registering a compound annual growth rate of 35.7%. Several factors are driving this growth during the forecast period, including the increasing incorporation of artificial intelligence into clinical trials, the broadening scope of precision medicine, the growing application of real-world data analytics, progress in cloud-based pharmaceutical platforms, and the creation of personalized therapeutics. Key trends shaping the period ahead encompass predictive models for drug discovery, optimization of clinical trials, utilization of real-world evidence, adoption of personalized medicine, and automation of regulatory compliance.
Download A Free Sample Report For Comprehensive Market Insights:
Machine Learning (ML) in The Pharmaceutical Industry Market Growth Momentum: Which Factors Are Influencing Demand?
The growing use of artificial intelligence (AI) is propelling machine learning (ML) forward within the pharmaceutical sector. AI refers to computer software that emulates human cognitive functions to execute intricate tasks like analysis, reasoning, and learning, whereas ML is a specialized branch of AI that relies on data-trained algorithms to generate models capable of handling complex operations. These technologies have already been applied to pharmaceutical innovation and drug delivery design, providing quicker solutions to difficult problems. They hold the promise of revolutionizing how drugs are delivered, improving decision-making instruments, and managing vast volumes of data to enable more efficient choices. For example, as reported by Forbes in June 2023, around 432,000 UK organizations—equivalent to one in six—have integrated at least one AI technology. Furthermore, AI adoption rates include 68% of large enterprises, 33% of medium-sized firms, and 15% of small businesses. Consequently, the rising prevalence of AI is expected to further accelerate ML adoption in the pharmaceutical industry.
Machine Learning (ML) in The Pharmaceutical Industry Market Segment Analysis: What Are The Major Market Categories?
The machine learning (ml) in the pharmaceutical industry market covered in this report is segmented –
1) By Component: Solution, Services
2) By Deployment: Cloud, On-premise
3) By Enterprise Size: Small and Medium Enterprises (SMEs), Large Enterprises
Subsegments:
1) By Solution: Drug Discovery Platforms, Predictive Analytics Tools, Clinical Trial Optimization Solutions, Patient Data Management Systems, Personalized Medicine Applications
2) By Services: Consulting Services, Implementation And Integration Services, Data Analysis And Modeling Services, Training And Support Services, Managed Services
Machine Learning (ML) in The Pharmaceutical Industry Market Trends Reshaping Industry Growth
Leading firms in the pharmaceutical machine learning (ML) sector are concentrating on creating intuitive software platforms—like drug discovery software—to enhance their ability to identify new drugs. Drug discovery software is an expansive category that includes various specialized tools and platforms employed during the identification and development of novel pharmaceutical compounds. As an example, in December 2023, Merck & Co. Inc., an American pharmaceutical corporation, unveiled the AIDDISON drug discovery software. This marks the first software-as-a-service solution that merges drug discovery and synthesis by leveraging generative AI, machine learning, and computer-aided drug design. With this platform, laboratories can identify suitable drug candidates within a vast chemical space, perform virtual screening of compounds drawn from a pool of over 60 billion chemical targets, and assess synthesis pathways to enable safer, more economical, and higher-yielding drug production.
Machine Learning (ML) in The Pharmaceutical Industry Market Leading Companies Driving Competitive Growth
Major companies operating in the machine learning (ml) in the pharmaceutical industry market are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs
Access The Complete Machine Learning (ML) in The Pharmaceutical Industry Market Report:
Machine Learning (ML) in The Pharmaceutical Industry Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the machine learning in the pharmaceutical industry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
